albuterol has been researched along with Adult Spinal Muscular Atrophy in 7 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Khirani, S | 1 |
Dabaj, I | 1 |
Amaddeo, A | 1 |
Olmo Arroyo, J | 1 |
Ropers, J | 1 |
Tirolien, S | 1 |
Coudert, V | 1 |
Estournet, B | 1 |
Fauroux, B | 1 |
Quijano-Roy, S | 1 |
Pera, MC | 1 |
Luigetti, M | 1 |
Sivo, S | 1 |
Lapenta, L | 1 |
Granata, G | 1 |
Antonaci, L | 1 |
Coratti, G | 1 |
Forcina, N | 1 |
Pane, M | 3 |
Mercuri, E | 3 |
Tiziano, FD | 3 |
Lomastro, R | 2 |
Abiusi, E | 1 |
Pasanisi, MB | 2 |
Di Pietro, L | 1 |
Fiori, S | 2 |
Baranello, G | 1 |
Angelini, C | 1 |
Sorarù, G | 1 |
Gaiani, A | 1 |
Mongini, T | 1 |
Vercelli, L | 1 |
Vasco, G | 1 |
Vita, G | 2 |
Messina, S | 2 |
Petillo, R | 1 |
Passamano, L | 1 |
Politano, L | 1 |
Campanella, A | 1 |
Mantegazza, R | 1 |
Morandi, L | 2 |
Mack, SG | 1 |
Cook, DJ | 1 |
Dhurjati, P | 1 |
Butchbach, ME | 1 |
Giovannetti, AM | 1 |
Černiauskaitė, M | 1 |
Bussolino, C | 1 |
Leonardi, M | 1 |
Pinto, AM | 1 |
D'Amico, A | 1 |
Angelozzi, C | 2 |
Bertini, E | 1 |
Neri, G | 2 |
Brahe, C | 2 |
Borgo, F | 1 |
Martella, A | 1 |
2 trials available for albuterol and Adult Spinal Muscular Atrophy
Article | Year |
---|---|
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adult; Aged; Aged, 80 and over; Albuterol; Biomarke | 2019 |
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design.
Topics: Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Child; Child, Preschool; Female; Gene Express | 2010 |
5 other studies available for albuterol and Adult Spinal Muscular Atrophy
Article | Year |
---|---|
Effect of Salbutamol on Respiratory Muscle Strength in Spinal Muscular Atrophy.
Topics: Administration, Oral; Albuterol; Bronchodilator Agents; Child; Child, Preschool; Female; Humans; Mal | 2017 |
Does albuterol have an effect on neuromuscular junction dysfunction in spinal muscular atrophy?
Topics: Albuterol; Child; Female; Humans; Male; Middle Aged; Muscular Atrophy, Spinal; Neuromuscular Agents; | 2018 |
Systems biology investigation of cAMP modulation to increase SMN levels for the treatment of spinal muscular atrophy.
Topics: Albuterol; Bucladesine; Colforsin; Cyclic AMP; Epinephrine; Fibroblasts; Fluorescent Antibody Techni | 2014 |
Perceived efficacy of salbutamol by persons with spinal muscular atrophy: A mixed methods study.
Topics: Adult; Albuterol; Bronchodilator Agents; Female; Humans; Longitudinal Studies; Male; Middle Aged; Mu | 2016 |
Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells.
Topics: Adrenergic beta-Agonists; Albuterol; Cyclic AMP Response Element-Binding Protein; Exons; Fibroblasts | 2008 |